SynthesisPharmacotherapy2021

Beneficial and harmful outcomes of tocilizumab in severe COVID-19: A systematic review and meta-analysis.

Manuel Rubio-Rivas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.